Traditional Chinese medication for cardiovascular disease

Nature Reviews Cardiology

Volumn 12, Issue 2, 2015, Pages 115-122

  Hao, Pan Pan ^a   Jiang, Fan ^a   Chen, Yu Guo ^a   Yang, Jianmin ^a   Zhang, Kai ^a   Zhang, Ming Xiang ^a   Zhang, Cheng ^a   Zhao, Yu Xia ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASIAN; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CHINESE MEDICINE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; METHODOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CORONARY DISEASE; PROCEDURES;

HERBACEOUS AGENT;

ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DRUGS, CHINESE HERBAL; HEART FAILURE; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84923176781     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.177     Document Type: Review

References (92)

1. WHO. About cardiovascular diseases [online], http://www.who.int/cardiovascular-diseases/about-cvd/en (2014).
2. Ridker, P. M. et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352, 20-28 (2005).
3. Karalliedde, L. & Gawarammana, I. Traditional herbal medicines: a guide to their safer use (Hammersmith Press, 2007).
4. Chen, K. J. & Lu, A. P. Situation of integrative medicine in China: results from a national survey in 2004. Chin. J. Integr. Med. 12, 161-165 (2006).
5. Guo, X. Y. et al. Use of traditional Chinese medicine in Chinese patients with coronary heart disease. Biomed. Environ. Sci. 26, 303-310 (2013).
6. Tachjian, A., Maria, V. & Jahangir, A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J. Am. Coll. Cardiol. 55, 515-525 (2010).
7. Vogel, J. H. et al. Integrating complementary medicine into cardiovascular medicine: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J. Am. Coll. Cardiol. 46, 184-221 (2005).
8. Yen, L., Jowsey, T. & McRae, I. S. Consultations with complementary and alternative medicine practitioners by older Australians: results from a national survey. BMC Complement. Altern. Med. 13, 73 (2013).
9. Team, V., Canaway, R. & Manderson, L. Integration of complementary and alternative medicine information and advice in chronic disease management guidelines. Aust. J. Prim. Health 17, 142-149 (2011).
10. Moher, D., Jones, A. & Lepage, L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285, 1992-1995 (2001).
11. Leucht, S., Wahlbeck, K., Hamann, J. & Kissling, W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361, 1581-1589 (2003).
12. Hao, P. P., Chen, Y. G., Wang, X. L. & Zhang, Y. Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials. Tex. Heart Inst. J. 37, 516-524 (2010).
13. Lu, Z. et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am. J. Cardiol. 101, 1689-1693 (2008).
14. Liu, H. Y. et al. Protective effect of Chinese herbs for supplementing Qi, nourishing Yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention. Chin. J. Integr. Med. 18, 423-430 (2012).
15. He, Q. Y. et al. Effect of Yiqi Yangyin decoction on the quality of life of patients with unstable angina pectoris. Chin. J. Integr. Med. 16, 13-18 (2010).
16. Zou, J. G., Zhang, J., Jia, Z. H. & Cao, K. J. Evaluation of the traditional Chinese Medicine Shensongyangxin capsule on treating premature ventricular contractions: a randomized, double-blind, controlled multicenter trial. Chin. Med. J. (Engl.) 124, 76-83 (2011).
17. Liu, Y., Li, N., Jia, Z., Lu, F. & Pu, J. Chinese medicine shensongyangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial. Evid. Based Complement. Alternat. Med. 2014, 605714 (2014).
18. Li, X. et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J. Am. Coll. Cardiol. 62, 1065-1072 (2013).
19. Chen, X. J. The clinical observation on a combined treatment of hypertension with traditional Chinese medicine and Western medicine, a report of 50 Cases [Chinese]. Shanxi J. Trad. Chin. Med. 24, 27-28 (2008).
20. Chen, L. Q. The clinical observation on the therapy enriching Yin and suppressing Yang for senile hypertension [Chinese]. J. Emerg. Trad. Chin. Med. 16, 518-519 (2007).
21. Chen, L. Q. The effects of decoctions of Pinellia ternata plus Atractylodes macrocephala rhizome, tall gastrodia plus Alisma spp. on body-mass index and depressurization of patients with hypertension, type of accumulation of Phlegm-Damp in TCM [Chinese]. J. Emerg. Trad. Chin. Med. 16, 650-651 (2007).
22. Wang, L., Gao, S. R., Lu, W. Q. & Wang, Q. C. The effects of erbai jiangya decoction on essential hypertension [Chinese]. J. N. Chin. Med. 44, 14-15 (2012).
23. Wu, Q., Shao, C. L., Liu, Y. M. & Wang, X. L. A clinical study of the effect of sini decoction on essential hypertension with Yang deficiency [Chinese]. Liaoning J. Trad. Chin. Med. 40, 2480-2482 (2013).
24. Cheng, G. S. The effectiveness of a combination of traditional Chinese medicine with Western medicine in patients with essential hypertension [Chinese]. Trad. Chin. Med. Res. 25, 15-17 (2012).
25. Cai, C. L. et al. Effects of the decoction of tall gastrodia and Uncaria tomentosa on serum SOD and MDA of patients with hypertension in the pattern of ascendant liver Yang [Chinese]. Household Med. J. 21, 321-322 (2005).
26. Xing, Z. H. et al. Effect of the decoction of tall gastrodia and Uncaria tomentosa on blood pressure and CAT in hypertensive patients [Chinese]. Chin. J. Clin. Rehabil. 8, 330-331 (2004).
27. Qiu, Z. A. The effects of the decoction of tall gastrodia and Uncaria tomentosa on essential hypertension [Chinese]. Chin. J. Exp. Trad. Med. Formulae 17, 252-253 (2011).
28. Jin, L. L., Ding, D., Guo, Y. P., Huang, P. H. & Wang, Q. H. The effects of compound qima capsules on isolated systolic hypertension [Chinese]. J. Guangzhou Univ. Trad. Chin. Med. 27, 217-221 (2010).
29. Nie, C. Y. A clinical study of the effectiveness of a combination of traditional Chinese medicine and Western medicine in patients with stable angina [Chinese]. Beijing J. Trad. Chin. Med. 30, 609-611 (2011).
30. Ding, X. M., Jia, L. Z. & Wang, C. H. The effects of compound danshen dripping pill on stable angina [Chinese]. Acta Academiae Medcinae Suzhou 19, 512-513 (1999).
31. Wang, J. S., Yuan, X. L. & Zhao, X. Y. The study on the compound salvia pellet in the treatment of coronary heart disease compared with isosoride dinitrate [Chinese]. Chin. J. Information Trad. Chin. Med. 10, 58-59 (2003).
32. Xu, X. M. Clinical observation of 160 patients with angina pectoris treated with compound danshen dripping pills [Chinese]. Chin. Trad. Herbal Drugs 31, 44 (2000).
33. Xu, K. H. A clinical study of the effectiveness of zhuyu decoction in patients with stable angina pectoris [Chinese]. Hunan J. Trad. Chin. Med. 28, 32-33 (2012).
34. Geng, X. Y. & Xiong, D. L. A clinical trial of the effects of a combination of traditional Chinese medicine and Western medicine on angina pectoris [Chinese]. J. Guiyang Coll. Trad. Chin. Med. 22, 14-15 (2000).
35. Guo, Q. H., Zhai, L. L. & Guo, H. The effects of a combination of yiqi huatan quyu formula and isosorbide dinitrate on angina pectoris [Chinese]. Chin. J. Integr. Med. Cardio-/Cerebrovasc. Dis. 4, 1007 (2006).
36. Huang, S. R. Effectiveness of Hewei Jiangzhuo Chinese herbal medicine in coronary heart disease [Chinese]. Guide China Med. 11, 330-331 (2013).
37. Li, C. L., Sun, J. J. & Zhang, W. X. A clinical study of the effectiveness of jiangtang shengmai decoction in patients with type 2 diabetes mellitus and coronary artery disease [Chinese]. Lishizhen Med. Materia Medica Res. 19, 1685-1686 (2008).
38. Luo, Y. H. The effects of maixuekang capsules on unstable angina [Chinese]. Chin. J. Integr. Med. Cardio-/Cerebrovasc. Dis. 11, 414 (2013).
39. Shao, G. L., Jiang, A. Q. & Zheng, F. S. A clinical study of the effectiveness of yangxinshi in patients with angina pectoris [Chinese]. Chin. J. Integr. Med. Cardio-/Cerebrovasc. Dis. 10, 643-644 (2012).
40. Wang, X. M., Li, Z. L., Zhai, Y. Q., Du, Z. L. & Wang, T. P. The effects of qingre jiedu huoxue jianpi decoction on angina pectoris [Chinese]. Clin. J. Trad. Chin. Med. 25, 315-316 (2013).
41. Yu, Y., Zeng, C. X. & Deng, X. Q. Usefulness of isosorbide mononitrate plus ershen pseudoginseng decoction to treat coronary heart disease [Chinese]. Med. Information Med. Surg. 22, 775-777 (2009).
42. Zeng, C. S. Investigation of the effects of tongxinluo capsule on coronary heart disease [Chinese]. Anhui Med. J. 31, 655-657 (2010).
43. Zhao, C. P. et al. A clinical study of the effectiveness of qishen yiqi pills in elderly patients with coronary heart disease [Chinese]. Acta Chin. Med. Pharmacol. 40, 113-114 (2012).
44. Zou, S. T. & Zhang, H. L. A clinical study of the effectiveness of tongxinluo in patients with coronary heart disease [Chinese]. Lishizhen Med. Materia Medica Res. 17, 1044 (2006).
45. Sun, L., Dai, P. S. & Shao, J. Treating 40 patients with coronary heart disease with compound danshen dripping pills [Chinese]. Tianjin J. Trad. Chin. Med. 17, 6-7 (2000).
46. Tan, R. J. The effects of Compound danshen dripping pills on angina pectoris [Chinese]. Chin. Community Doctors 11, 107-108 (2009).
47. Feng, J., Fang, R. L., Liu, J. Z. & Du, J. Q. A clinical study of the effectiveness of yiqi tongmai capsules in patients with coronary heart disease [Chinese]. Med. J. Chin. Civil Adm. 11, 224-226 (1999).
48. Guo, J. J., Wang, C., Cui, Y. Z. & Wei, Y. A clinical study of the effectiveness of shenhong huazhuo tongluo granules in patients with angina pectoris [Chinese]. Chin. J. Gerontol. 33, 1755-1756 (2013).
49. He, H. T., Guo, L. F., Duan, H. J., Geng, B. & Feng, Y. L. A clinical study of the effectiveness of ziyin qianyang huoxue formula in patients with coronary heart disease and hypertension [Chinese]. J. N. Chin. Med. 43, 17-18 (2011).
50. Jiang, P. & Zhang, M. A clinical study of the effectiveness of musk baoxin pills in patients with unstable angina [Chinese]. J. Liaoning Univ. TCM 13, 125-127 (2011).
51. Li, Y. H. & Wu, X. F. A clinical study of the effectiveness of xuefu zhuyu decoction in patients with angina pectoris [Chinese]. Jilin J. Trad. Chin. Med. 31, 1076-1077 (2011).
52. Xie, B. A clinical study of the effectiveness of shugan yiqi tongyu decoction in patients with angina pectoris [Chinese]. Shaanxi J. Trad. Chin. Med. 32, 816-817 (2011).
53. Xu, M. S., Xu, Z. P. & Chen, D. Y. The effects of buqi huayu decoction on angina pectoris [Chinese]. Jilin J. Trad. Chin. Med. 27, 16-17 (2007).
54. Zhang, C. Q., Zhang, W. N., Li, F. & Wang, F. L. Effect of guanxin tongluo capsules on the quality of life of patients with angina pectoris [Chinese]. Chin. Arch. Trad. Chin. Med. 24, 2029-2030 (2006).
55. Zhang, D. C., Li, G., Xing, J. & Chen, P. Y. Effects of Chinese herbs on angina pectoris [Chinese]. J. Emerg. Trad. Chin. Med.. 17, 906-907 (2008).
56. Zhu, C. A randomized clinical trial of sini decoction in 128 patients with angina pectoris [Chinese]. J. Prac. Trad. Chin. Med. 26, 15-16 (2012).
57. Liu, Y. A randomized control trial of shensong yangxin capsules in the treatment of coronary heart disease and ventricular premature beat [Chinese]. J. Pract. Trad. Chin. Intern. Med. 27, 8-9 (2013).
58. Li, X. B. & Zhou, H. X. A clinical study of the effectiveness of a combination of traditional Chinese medicine and Western medicine in patients with coronary artery disease and premature ventricular contraction [Chinese]. Henan Trad. Chin. Med. 24, 52-54 (2004).
59. Zhao, W. X., Yue, C. Z. & Jia, B. A clinical study of the effectiveness of a combination of yangxue fumai decoction and propafenone in patients with atrial fibrillation [Chinese]. Beijing J. Trad. Chin. Med. 28, 117-118 (2009).
60. Fu, H. B. et al. Effect of wenxin granules on premature ventricular contraction [Chinese]. Chin. Med. Mod. Dist. Edu. China 11, 15-16 (2013).
61. Sun, G. & Zhang, B. A clinical study of the effectiveness of wenxin granules on premature ventricular contraction [Chinese]. Chin. J. Basic Med. Trad. Chin. Med. 11, 793-794 (2005).
62. Wang, F. J., Ci, S. P. & Zhou, X. Y. A clinical study of the effectiveness of a combination of Buchang wenxin granules and Gamma oryzanol on premature contraction [Chinese]. Chin. J. Cardiovasc. Rehabil. Med. 14, 59-60 (2005).
63. Yu, S. Y. & Yu, S. Y. A clinical trial of the effectiveness of wenxin granules in patients with premature contraction [Chinese]. Chin. J. Clinicians 32, 62 (2004).
64. He, X. P., Chen, D. F., Zheng, J. H. & Deng, B. Effects of jianxin pinglu pills on cardiac arrhythmias and aquaporin protein-4 [Chinese]. Chin. Arch. Trad. Chin. Med. 22, 1017-1020 (2004).
65. Liang, B. W. A clinical study of the effectiveness of huangyangning in patients with cardiac arrhythmias [Chinese]. J. Pract. Med. 21, 1226-1228 (2005).
66. Mao, C. L. & Hu, M. X. The effectiveness of decoction of bupleurum root plus longmu in elderly patients with premature ventricular contraction [Chinese]. J. Sichuan Trad. Med. 16, 32-33 (1998).
67. Niu, T. F. & Zhang, X. G. A clinical study of the effectiveness of anfuer in patients with premature ventricular contraction [Chinese]. Shanxi J. Trad. Chin. Med. 16, 18-19 (2000).
68. Xue, C. L., Wu, J. X., Duan, H. J. & Sun, F. J. A clinical study of the effectiveness of dingxin granules in patients with coronary artery disease and premature ventricular contraction [Chinese]. J. Hebei Trad. Chin. Med. Pharmacol. 19, 10-12 (2004).
69. Sun, X. D. The effectiveness of a combination of traditional Chinese medicine and trimetazidine in patients with coronary artery disease and heart failure [Chinese]. Shandong J. Trad. Chin. Med. 32, 479-480 (2013).
70. Li, X. M., Yan, L. & Yu, R. Usefulness of traditional Chinese medicine injection in elderly patients with chronic systolic heart failure [Chinese]. Sichuan Med. J. 30, 863-864 (2009).
71. Ni, W. B. et al. Effectiveness of lixin decoction in patients with chronic systolic heart failure [Chinese]. J. Liaoning Univ. Trad. Chin. Med. 8, 107-108 (2006).
72. Zhang, G. H. A clinical trial of the effectiveness of a combination of traditional Chinese medicine and Western medicine in patients with chronic heart failure [Chinese]. Chin. J. Integr. Med. Cardio-/Cerebrovasc. Dis. 8, 739-740 (2010).
73. He, M. C. Effectiveness of a combination of traditional Chinese medicine and Western medicine in elderly patients with chronic systolic heart failure [Chinese]. J. Clin. Exp. Med. 6, 146-147 (2007).
74. Zhang, Y. & Zhou, M. Q. Effect of qili qiangxin capsules on chronic heart failure [Chinese]. Med. Innovation China 10, 16-17 (2013).
75. Gong, F. S. Effect of qiangxin kangshuai decoction on chronic congestive heart failure [Chinese]. J. Sichuan Trad. Chin. Med. 29, 72-74 (2011).
76. Qin, C. L., Cao, S. H. & Li, Y. F. Effect of a combination of qianglixin capsules and Western medicine on chronic congestive heart failure [Chinese]. For All Health. 7, 24 (2013).
77. Tan, W. M. Effect of shenqi yangxin decoction on chronic heart failure [Chinese]. China Mod. Med. 19, 109-110 (2012).
78. Tian, X. T. & Zhang, J. Z. A clinical trial of the effectiveness of a combination of traditional Chinese medicine and Western medicine in patients with coronary artery disease and heart failure [Chinese]. Shandong J. Trad. Chin. Med. 27, 396-397 (2008).
79. Yang, Q. H., Xing, J. E. & Li, Y. X. Effects of modified baoyuan decoction on levels of circulating angiotensin II and tumor necrosis factor in patients with chronic heart failure [Chinese]. Chin. J. Gerontol. 32, 271-272 (2012).
80. Zhang, J. H., Liu, Y. Y. & Lu, X. C. Effect of a combination of traditional Chinese medicine and Western medicine on chronic heart failure [Chinese]. J. Emerg. Trad. Chin. Med. 14, 712-713 (2005).
81. Liu, L. S. & Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guideline for the management of hypertension [Chinese]. Chin. J. Cardiol. 39, 579-615 (2011).
82. Ong, K. L., Cheung, B. M., Man, Y. B., Lau, C. P. & Lam, K. S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49, 69-75 (2007).
83. Li, W. et al. Association between blood pressure control and risk factor in community hypertensive patients [Chinese]. Chin. J. Public Health 28, 154-156 (2012).
84. Xu, J. & Yang, Y. Traditional Chinese medicine in the Chinese health care system. Health Policy 90, 133-139 (2009).
85. Xu, W., Towers, A. D., Li, P. & Collet, J. P. Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur. J. Cancer Care (Engl.) 15, 397-403 (2006).
86. Zhai, L. H. & Dong, S. G. Vascular endothelial dysfunction and cardiovascular diseases [Chinese]. Adv. Cardiovasc. Dis. 22, 112-114 (2001).
87. Wu, X. & Jiang, X. Systematic review and meta analysis of randomized controlled trials on Tianmagouteng decoction in treatment of primary hypertension with liver Yang hyperactivity syndrome. J. Trad. Chin. Med. 33, 15-18 (2013).
88. Heber, D. et al. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am. J. Clin. Nutr. 69, 231-236 (1999).
89. Wu, B. et al. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke 38, 1973-1979 (2007).
90. Chugh, S. S., Shen, W. K., Luria, D. M. & Smith, H. C. First evidence of premature ventricular complex-induced cardiomyophthy: a potentially reversible cause of heart failure. J. Cardiovasc. Electrophysiol. 11, 328-329 (2000).
91. Brignole, M. et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur. Heart J. 34, 2281-2329 (2013).
92. Gu, D. et al. Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population [Chinese]. Chin. J. Cardiol. 31, 3-6 (2003).